Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By

Showing results 21 - 30 of 45

Selected Filters:
7 July 2022

Developing and Introducing a Dual Prevention Pill- Oral PrEP & oral contraception for HIV and pregnancy prevention

A coalition of partners is developing a novel Dual Prevention Pill (DPP) for prevention of pregnancy and HIV acquisition in high-need countries. In East and Southern Africa — where the DPP is initially planned for introduction — 65 percent of new HIV infections are amongst women aged 15 and over, and 16 percent of women…

Community/Advocacy, Research

Document
7 July 2022

CHARISMA Mobile: Developing a Digital Resource for Empowerment Counseling, Community Health clinic model for Agency in Relationships and Safer Microbicide Adherence

CHARISMA is a PEPFAR- and USAID-funded empowerment counseling intervention designed to help women use oral pre-exposure prophylaxis and other antiretroviral-based HIV prevention technologies safely and effectively by addressing dynamics of their relationships with male partners, including exposure to intimate partner violence. The intervention, designed to be delivered by lay counselors, is being adapted into a…

Research, Service Delivery

Document
1 April 2022

Frequently Asked Questions about the Dual Prevention Pill

The Dual Prevention Pill (DPP) is a single, co-formulated, daily oral pill containing oral pre-exposure prophylaxis (PrEP) and combined oral contraception (COC) that prevents both HIV and pregnancy. The DPP will add to the contraceptive and HIV prevention toolbox and will be the first multi-purpose prevention technology (MPT) to go to market since male and…

Service Delivery

Document
1 December 2021

MOSAIC (Maximizing Options to Advance Informed Choice for HIV Prevention)

Short introduction to MOSAIC, a project working across multiple countries to implement user-centered research and research translation efforts to identify, understand, and remove barriers to new product introduction, access, and use; coordinate and provide technical assistance to global, national, and subnational stakeholders to expedite product launch and scale-up; and strengthen the capacity of a wide…

Research

Document
1 February 2021

CHOICE PROMISE: Preparing for Ring Opportunities through Market Introduction Support and Knowledge Exchange

Short introduction to PROMISE and CHOICE, consortiums supporting early product introduction planning for the dapivirine vaginal ring in sub-Saharan Africa.

Demand Creation/Marketing

Document
1 December 2020

PrEP for Pregnant and Breastfeeding People: Surveillance Tools Summary Brief (English)

A Summary Breif of Surveillance Tools for PrEP Use by Pregnant and Breastfeeding People

Monitoring & Evaluation, Service Delivery

Document
1 November 2020

What is CHOICE?

An overview of the CHOICE project

Demand Creation/Marketing, Research, Service Delivery

Document
23 June 2020

What End-Users Think About HIV Prevention Products and Multipurpose Prevention Technologies (MPT)

The Tablets, Ring, Injections as Options study, or TRIO, was conducted with young women aged 18 to 30 in Kisumu, Kenya and Soshanguve, South Africa between 2015 and 2017. The study examined young women's perspectives on future MPT in a clinical study of three placebo MPT products.

Research

Document
23 June 2020

Listening to Young Women in Kenya and South Africa to Inform Multipurpose “2-in-1” Products for HIV and Pregnancy Prevention

The Tablets, Ring, Injections as Options study, or TRIO, was conducted with young women aged 18 to 30 in Kisumu, Kenya and Soshanguve, South Africa between 2015 and 2017. The study examined young women's perspectives on future MPT in a clinical study of three placebo MPT products. TRIO identified anticipated enablers and barriers to adoption…

Research

Document
12 May 2020

We Are The Generation

The OPTIONS Consortium supported the National Department of Health, South Africa, with the development of information, education and communication (IEC) materials for the launch of oral PrEP for female sex workers, men who have sex with men and university students. These materials were designed with inputs from local South African sex worker, MSM and youth…

Demand Creation/Marketing